Filing Details

Accession Number:
0001562180-23-008172
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-06 17:20:23
Reporting Period:
2023-12-04
Accepted Time:
2023-12-06 17:20:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1314102 Eyepoint Pharmaceuticals Inc. EYPT Laboratory Analytical Instruments (3826) 262774444
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1904458 Craig Michael Pine 480 Pleasant St, Ste A210
Watertown MA 02472
Chief Corp Dev.&Strat. Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-12-04 45,000 $12.62 50,343 No 4 M Direct
Common Stock Disposition 2023-12-04 45,000 $22.00 5,343 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-12-04 45,000 $0.00 45,000 $12.62
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
55,000 2032-01-10 No 4 M Direct
Footnotes
  1. Includes 2,159 shares acquired on January 31, 2023 and 2,184 shares acquired on July 31,2023 pursuant to EyePoint's 2019 Employee Stock Purchase Plan.
  2. The option to purchase will vest and become exercisable as follows: 25% at January 10th, 2023 and the remainder ratably, on a monthly basis, over the remaining three years.